Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase (Q77801174)
Jump to navigation
Jump to search
scientific article published on 01 April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase |
scientific article published on 01 April 2002 |
Statements
Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase (English)
Heyo K Kroemer
Thomas E Mürdter
Godehard Friedel
Janne T Backman
Monika McClellan
Monika Schick
Manfred Gerken
Klaus Bosslet
Peter Fritz
Heikki Toomes
Bernhard Sperker